<DOC>
	<DOCNO>NCT00869869</DOCNO>
	<brief_summary>The purpose study determine whether melatonin improve sleep , quality life marker heart failure patient heart failure .</brief_summary>
	<brief_title>Melatonin Supplementation Improve Sleep Patients With Heart Failure</brief_title>
	<detailed_description>Heart failure affect nearly 5 million individual United States constitute prime risk factor morbidity mortality . Beta-blockers class drug form critical part best treatment heart failure , thereby decrease risk serious problem . Beta-blockers also low level melatonin , hormone sleep-promoting effect . Most patient heart failure take beta-blockers poor sleep , may relate beta-blockers ' effect melatonin level . This study evaluate effectiveness treatment melatonin supplement improve sleep individual heart failure take beta-blockers . In addition , study examine whether melatonin supplement aid improving quality life measure heart failure . Participants double-blind study randomly assign receive either melatonin supplement placebo duration study . The study mainly take place home , participant complete sleep diary , measure blood pressure wear wrist watch measure movement 5-6 week . During time three visit hospital plasma urine sample collect questionnaire complete .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Central Nervous System Depressants</mesh_term>
	<mesh_term>Molecular Mechanisms Pharmacological Action</mesh_term>
	<criteria>Diagnosed heart failure NYHA Class 2 3 Currently treat betablocker Diagnosed obstructive sleep apnea Using Fluvoxamine , Warfarin , Nifedipine , Calcium Channel Blockers</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Sleep Disorders</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>Molecular Mechanisms Pharmacological Action</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Central Nervous System Depressants</keyword>
	<keyword>Protective Agents</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Signs Symptoms</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Neurologic Manifestations</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Central Nervous System Agents</keyword>
</DOC>